6d5d404f-85c2-416c-a51e-21958e42b6e4.pdf


Date: 30 March 2016


Board appointment


The Board of Sigma Pharmaceuticals Limited (Sigma) is pleased to announce that Ms Christine Bartlett will join the Board as an independent Non-Executive Director, effective 30 March 2016. Ms Bartlett will also be a member of Sigma's People and Remuneration Committee.


Ms Bartlett holds a Bachelor of Science (Pharmacology and Physiology) from the University of Sydney and has also completed Harvard University's Advanced Management and Global Executive Program. As an experienced CEO and senior executive, Ms Bartlett has broad commercial expertise, with a particular focus in the areas of financial discipline, risk management, innovation, technology, and strategy execution.


Ms Bartlett's current directorships in listed entities include Non-Executive Director at Mirvac Group and GBST Ltd. Ms Bartlett has not held any other Directorships in listed entities over the past three years. In addition, Ms Bartlett's current directorships in unlisted companies include Non-Executive Director of Clayton Utz and The Smith Family.


Ms Bartlett is a member of UNSW Australian School of Business Advisory Board, Chief Executive Women, and the Australian Institute of Company Directors.


For more information please contact:

Gary Woodford

Corporate Affairs Manager gary.woodford@signet.com.au 0417 399 204

Sigma Pharmaceuticals Limited issued this content on 30 March 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 March 2016 23:15:10 UTC

Original Document: http://phx.corporate-ir.net/external.file?t=2&item=o8hHt16027g9XhJTr8+weNRYaV9bFc2rMd0Q/AXw4ztCFNxrROIKYE+bmcmAZXbhMuZ5v/NshIvNzpx8Ml19ldxjz/WDdKgJl0NaqTMPZ1OKcTbey8ScW7W9Hyh//0PCmlnJL3wa4h2uyEr5BO5QVQ==&cb=635948896596750304